ERNA Ernexa Therapeutics Inc.
Nasdaq · SEC CIK 748592 · EDGAR
- Bought, last 12 months
- $2.00M 1 purchases by 1 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 63 since 2021-07-19, latest 2026-09-01 21:59
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Cherington Charles | 10% | $2.00M | — |
Transactions 22
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-17 | 2026-02-10 | ERNA | Cherington Charles | 10% | P - Purchase | $0.5 | +4.00M | 6.78M | +144% | +$2.00M |
| D | 2025-07-07 | 2025-06-21 | ERNA | Gurrola Sandra M | SVP of Fin | M - OptEx | — | +30 | 110 | +38% | — |
| 2025-06-11 | 2025-06-09 | ERNA | Cherington Charles | 10% | P - Purchase | $0.1 | +21.24M | 41.66M | +104% | +$2.12M | |
| DMA | 2025-05-07 | 2024-09-24 | ERNA | Cherington Charles | 10% | P - Purchase | — | +13.25M | 818.2K | New | — |
| 2025-04-04 | 2025-04-02 | ERNA | Cherington Charles | 10% | P - Purchase | $0.1 | +3.77M | 20.40M | +23% | +$376.8K | |
| DM | 2024-11-05 | 2024-10-29 | ERNA | Cherington Charles | 10% | P - Purchase | — | +13.25M | 818.2K | New | — |
| D | 2024-11-05 | 2024-10-29 | ERNA | Cherington Charles | 10% | C - Cnv Deriv | $0.5 | +2.82M | 16.63M | +20% | +$1.41M |
| D | 2024-06-25 | 2024-06-21 | ERNA | Gurrola Sandra M | SVP of Fin | M - OptEx | — | +437 | 1,365 | +47% | — |
| D | 2024-06-25 | 2024-06-21 | ERNA | Gurrola Sandra M | SVP of Fin | F - Tax | $1.94 | -180 | 1,185 | -13% | -$349.20 |
| D | 2023-06-23 | 2023-06-21 | ERNA | Gurrola Sandra M | VP of Fin | F - Tax | $2.48 | -179 | 928 | -16% | -$443.92 |
| D | 2023-06-23 | 2023-06-21 | ERNA | Gurrola Sandra M | VP of Fin | M - OptEx | — | +438 | 1,107 | +65% | — |
| D | 2022-12-06 | 2022-12-02 | ERNA | Cherington Charles | Dir, 10% | P - Purchase | $3.28 | +261.8K | 556.5K | +89% | +$858.6K |
| DMI | 2022-12-06 | 2022-12-02 | ERNA | Singer Nicholas Jason | Dir | P - Purchase | $3.28 | +283.3K | 121.8K | New | +$929.2K |
| DI | 2022-12-05 | 2022-12-02 | ERNA | HALPERN JOHN D | 10% | P - Purchase | $3.28 | +335.9K | 451.0K | +292% | +$1.10M |
| D | 2022-09-21 | 2022-09-20 | ERNA | Sidhu Roger | Chief Medical Off | M - OptEx | — | +20.2K | 20.2K | New | — |
| D | 2022-06-29 | 2022-06-28 | ERNA | DAmour Kevin | CSO | M - OptEx | — | +17.6K | 17.6K | New | — |
| D | 2022-06-29 | 2022-06-28 | ERNA | DAmour Kevin | CSO | F - Tax | $0.55 | -6,077 | 11.5K | -35% | -$3,342 |
| D | 2022-06-23 | 2022-06-21 | ERNA | Gurrola Sandra M | VP of Fin | M - OptEx | — | +8,750 | 17.0K | +107% | — |
| D | 2022-06-23 | 2022-06-21 | ERNA | Gurrola Sandra M | VP of Fin | F - Tax | $0.48 | -3,586 | 13.4K | -21% | -$1,721 |
| D | 2021-12-10 | 2021-06-01 | ERNA | Cherington Charles | Dir | J - Other | $0.00 | +92 | 5.89M | +0.0% | $0 |
| MI | 2021-08-20 | 2021-07-08+ | ERNA | DENNY GEORGE P III | 10% | P - Purchase | $13.48 | +3 | 1 | New | +$40.45 |
| I | 2021-08-20 | 2021-07-06 | ERNA | DENNY GEORGE P III | 10% | S - Sale | $16.06 | -75.0K | 4.78M | -2% | -$1.20M |
Purchase Sale Sale after option exercise All abbreviations